No subscription option is available
That said, please remember that we are not medical professionals, and seeking the guidance of your doctor is always recommended
Second Natures peer-reviewed study published in JMIR Formative Research (2025) compared both medications within our programme: 3 Tirzepatide (Mounjaro) cohort (209 people): 22.1% average weight loss at 12 months 95.2% achieved at least 10% weight loss 83.7% achieved at least 15% weight loss Semaglutide (Wegovy) cohort (130 people): 17.1% average weight loss at 12 months 83.1% achieved at least 10% weight loss 56.2% achieved at least 15% weight loss Both cohorts exceeded clinical trial results, suggesting that comprehensive behavioural support enhances outcomes regardless of which medication you use
Luckily, were still your source for all things GLP-1: Affordable GLP-1s Oral medication formats Coaching and lifestyle support This is the clinic we trust for transparency, results, and support that go way beyond the prescription
Emagrecimentos rpidos prometidos por produtos sem procedncia podem envolver substncias no declaradas, doses inadequadas ou at contaminantes
The combination of both is recommended through multiple studies